Bio-Rad Laboratories Inc Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 9/6/2026)
| Balance Sheet | Total Assets | 10,576,500,000.00 | ROE | 70.47 % |
| Balance Sheet | Total Equity | 7,453,600,000.00 | ROA | 7.18 % |
| Cashflow | Capital Expenditures | -157,600,000.00 | P/FCF | 26.39 |
| Cashflow | Free Cash Flow | 331,800,000.00 | – | – |
| Cashflow | Operating Cash Flow | 532,200,000.00 | P/CF | 18.58 |
| Income | Earnings per Share (diluted) | 27.85 | Div. Yield | – |
| Income | Net Income | 187,900,000.00 | P/E | 13.01 |
| Income | Shares Outstanding | 27,281,000.00 | P/B | 1.33 |
| Income | Total Revenue | 460,600,000.00 | P/S | 3.83 |
Ratios calculated on: 10/14/2026
Company Description
Founded in 1952 and incorporated in 1957, Bio-Rad Laboratories, Inc. was initially engaged in the development and production of specialty chemicals used in biochemical, pharmaceutical and other life science research applications. We entered the field of clinical diagnostics with the development of our first test kit based on separation techniques and materials developed for life science research. Through internal research and development efforts and acquisitions we have expanded into various markets. Today, Bio-Rad manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.bio-rad.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more